MiNK Therapeutics Inc (INKT) Stock Price

11.91 ▲ +0.27 (+2.32%)
Open: 11.82 Vol: 13.99K Day's range: 11.625 - 12.03 Jun 29, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
INKT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY BUY NEUTRAL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 12.00▼ 11.87▲ 11.87▲ 11.86▲ 11.92▼
MA10 11.85▲ 11.82▲ 11.83▲ 12.02▼ 11.60▲
MA20 11.85▲ 11.93▲ 11.95▲ 12.08▼ 11.28▲
MA50 12.04▼ 12.08▼ 12.07▼ 11.61▲ 12.45▼
MA100 12.11▼ 12.08▼ 11.98▼ 11.24▲ 10.80▲
MA200 12.01▼ 11.61▲ 11.74▲ 12.13▼ 13.34▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.047▲ 0.029▲ 0.024▲ -0.077▼ 0.145▲
RSI 50.257▲ 50.405▲ 50.380▲ 50.860▲ 50.968▲
STOCH 66.416     52.316     52.687     43.517     53.788    
WILL %R -34.444     -34.444     -34.444     -50.000     -54.865    
CCI 38.824     57.481     55.135     -60.586     25.302    
Latest Filters Detected On INKT
RSI $INKT RSI(14) Crossed Above 50 Set Alert
MA $INKT Price Crossed Above MA(50) Set Alert
MA $INKT Price Crossed Above MA(26) Set Alert
MiNK Therapeutics Inc News
MiNK Therapeutics Corporate Event Calendar | NASDAQ:INKT
Friday, May 29, 2026 04:59 PM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for MiNK Therapeutics Inc. Use the full market events calendar to scan activity across all tickers.
MiNK Therapeutics Inc (INKT) Q1 2026 Earnings Call Highlights: Strategic Advances and Financial ...
Friday, May 15, 2026 04:01 PM
MiNK Therapeutics Inc (NASDAQ:INKT) presented data at four major international scientific meetings, showcasing their progress in pulmonary fibrosis, refractory gastric cancer, and severe lung injury.
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
Friday, May 08, 2026 01:30 PM
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE)-- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to ...
INKT historical stock data
date open high low close volume
29/06/26 11.82 12.03 11.625 11.91 13,992
26/06/26 11.52 11.97 11.10 11.64 34,254
25/06/26 11.975 12.07 11.31 11.31 14,195
24/06/26 12.50 12.55 12.0102 12.11 7,011
23/06/26 11.88 12.58 11.88 12.33 22,778
22/06/26 12.33 12.51 12.01 12.25 19,818
18/06/26 12.3502 12.445 11.86 12.14 13,727
17/06/26 12.2697 12.6263 11.869 12.21 22,746
16/06/26 12.5597 12.5597 11.6701 11.81 22,193
15/06/26 12.29 12.72 11.96 12.535 27,530
Quote Details
52wk Low:7.01
52wk High:76.00
Vol:13.99K
Avg Vol(3m):841.1K
1Y Chng:-57.48%
1M Chng:+11.10%
Add to Watch List
More Information
Index US Composite
Market Cap. 58.89M